ISAR-SAFE - Placebo-Controlled Trial of 6 vs. 12 Months Clopidogrel Therapy After Implantation of a Drug-Eluting Stent
Project objectivesA multicenter, randomized study comparing two antiplatelet strategies after drug-eluting stent implantation. Specifically, the safety and efficacy of a 6-month course of dual antiplatelet therapy (clopidogrel and aspirin) is compared with the conventional 12-month course prescribed by the product information sheet and guidelines. |
Start and end date |
|
October 2011 - January 2014 (results presented in November 2014) |
Project Manager |
|
Prof. Germano Di Sciascio |
Coordinating institution of the project |
|
ISAR Center - Munich |
